These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 36014889)

  • 1. Vitamin-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis.
    Zhai Z; Dong W; Sun Y; Gu Y; Ma J; Wang B; Cao H
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D in inflammatory bowel disease: more than just a supplement.
    Gubatan J; Moss AC
    Curr Opin Gastroenterol; 2018 Jul; 34(4):217-225. PubMed ID: 29762159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis.
    Ahmad R; Kumar B; Thapa I; Talmon GA; Salomon J; Ramer-Tait AE; Bastola DK; Dhawan P; Singh AB
    Gut Microbes; 2023 Dec; 15(2):2282789. PubMed ID: 38010872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases.
    Battistini C; Ballan R; Herkenhoff ME; Saad SMI; Sun J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease and carcinogenesis.
    Nagao-Kitamoto H; Kitamoto S; Kamada N
    Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
    Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
    World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal anesthesia alleviates dextran sodium sulfate-induced colitis by modulating the gut microbiota.
    Hong Y; Zhao J; Chen YR; Huang ZH; Hou LD; Shen B; Xin Y
    World J Gastroenterol; 2022 Mar; 28(12):1239-1256. PubMed ID: 35431512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota.
    Zhang H; Shi Y; Lin C; He C; Wang S; Li Q; Sun Y; Li M
    Front Immunol; 2023; 14():1338918. PubMed ID: 38288125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal obesity during pregnancy leads to derangements in one-carbon metabolism and the gut microbiota: implications for fetal development and offspring wellbeing.
    Rubini E; Schenkelaars N; Rousian M; Sinclair KD; Wekema L; Faas MM; Steegers-Theunissen RPM; Schoenmakers S
    Am J Obstet Gynecol; 2022 Sep; 227(3):392-400. PubMed ID: 35452650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
    Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
    Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.